| EPC323 | 'I was scared dating… who would take me with my status?' Living with HIV in the UTT era in Johannesburg, South Africa | E-poster | Measuring and enhancing retention and adherence in HIV prevention programmes |
| EPC322 | Acceptability of an mHealth intervention to promote the use of pre-exposure prophylaxis among individuals at increased risk of HIV. The case of the Jichunge smartphone app in Dar es Salaam, Tanzania | E-poster | Measuring and enhancing retention and adherence in HIV prevention programmes |
| EPC321 | Retention of clients on daily oral HIV pre-exposure prophylaxis in Vietnam | E-poster | Measuring and enhancing retention and adherence in HIV prevention programmes |
| EPC320 | Identification of viral mutations that confer cross resistance to VRC01 antibody in HIV-1 subtype C viruses | E-poster | Other new HIV prevention tools |
| EPC319 | Lactobacillus spp interaction with neat and formulated Griffithsin, a candidate for topical HIV prevention | E-poster | Other new HIV prevention tools |
| EPC318 | Acceptability of broadly neutralizing antibodies (bNAbs) for HIV prevention: a qualitative investigation among Adolescent Girls and Young Women (AGYW) in India | E-poster | Other new HIV prevention tools |
| EPC317 | Attitudes and Beliefs regarding an HIV preventive vaccine among sexual and gender minorities in Brazil | E-poster | Other new HIV prevention tools |
| EPC316 | A qualitative inquiry on potential barriers to provision and use of the PrEP ring in Kenya | E-poster | Other new HIV prevention tools |
| EPC315 | Obstacles to using event-driven (2-1-1) PrEP: exploring the role of reported barriers on PrEP dosing choice in a national US sample | E-poster | Other new HIV prevention tools |
| EPC314 | Considerations for the delivery of new biomedical HIV prevention methods: Zimbabwe healthcare provider perspectives | E-poster | Other new HIV prevention tools |